Stock of Boulder, Colo.-based Synergen Corp. closed up $3.88 onFriday at $48.88 after positive comments by several analystsand an investment manager in the Sept. 2 issue of BusinessWeek.
Investment manager Wayne Greene, president of AmericanInvestors Growth Fund, characterized Synergen as "the nextAmgen." Greene, who has been buying Synergen stock(NASDAQ:SYGN), said the company had "the best batch ofimportant biopharmaceuticals that will hit the market" in themid-1990s.
Analysts Warren Lammert of Janus Capital and Mark Simon ofRobertson, Stephens & Co. said they expected the stock price torise substantially in the next year.
(c) 1997 American Health Consultants. All rights reserved.